LSDIF — Lucy Scientific Discovery Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$0.14m
- $0.01m
Annual cashflow statement for Lucy Scientific Discovery, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS/A | PROSPECTUS/A | PROSPECTUS/A | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -3 | -4.73 | -5.86 | -8.99 |
| Non-Cash Items | 2.02 | 3.48 | 2.6 | 4.58 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 0.484 | -0.237 | 0.841 | 0.143 |
| Change in Accounts Receivable | ||||
| Change in Prepaid Expenses | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Change in Payable / Accrued Expenses | ||||
| Cash from Operating Activities | -0.499 | -1.48 | -2.42 | -4.27 |
| Capital Expenditures | — | 0 | -0.034 | -0.3 |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | — | — | — | 0.034 |
| Sale of Fixed Assets | ||||
| Cash from Investing Activities | — | 0 | -0.034 | -0.266 |
| Financing Cash Flow Items | 0.381 | 0.707 | -0.667 | -1.44 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 0.535 | 1.7 | 2.25 | 6.19 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 0.038 | 0.196 | -0.193 | 1.62 |